Research programme: opioid analgesics - Heron TherapeuticsAlternative Names: APF580
Latest Information Update: 15 Jan 2014
At a glance
- Originator A.P. Pharma
- Developer Heron Therapeutics
- Mechanism of Action Opioid receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Suspended Cancer pain; Pain; Postoperative pain